BezerraT.G., GonçalvesA.L.G., FrancoA.M., RossiB.A., GazzoniG.A.S., WinterM.L., MarquesM.O., BarkS., CruzV.S. and RêgoR.C.L. 2021. Cardiovascular repercussions of the use of SGLT2 inhibitors in patients with type 2 Diabetes Mellitus. Electronic Journal Collection Health. 13, 5 (May 2021), e6890. DOI:https://doi.org/10.25248/reas.e6890.2021.